Search - tctmd.com

Displaying 521 - 540 of 2439

Sort: Relevancy | Date

Presentation LINC 2019

Insight from AcoArt I5 Year Follow Up

Presenter: Dierk Scheinert

January 25, 2019

Presentation

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

January 15, 2019

Presentation VIVA 2018

LUTONIX BTK Trial

Presenter: Jihad Mustapha

November 09, 2018

Presentation VIVA 2018

TOBA II 12-Month Data

Presenter: William Gray

November 09, 2018

Presentation VIVA 2018

1-Year Outcomes for Eluvia in Long Lesions

Presenter: William A. Gray

November 09, 2018

Presentation Cardiovascular Interventions 2018

Show me the Data: Key Clinical Trials of 2018

Presenter: Ehtisham Mahmud

October 26, 2018

Presentation Cardiovascular Interventions 2018

So Many Choices – How Do I Choose a Stent in 2018?

Presenter: James Hermiller

October 26, 2018

Presentation TCT Abstracts Posters 2018

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

Presenter: Hyungdon Kook

September 25, 2018

Presentation TCT 2018

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Presenter: James B. Hermiller Jr, Hiroki Shiomi

September 25, 2018

Presentation TCT 2018

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Presenter: Felix Mahfoud, Patrick W. Serruys, Pieter C. Smits

September 25, 2018

Presentation TCT Abstracts Posters 2018

Drug transfer to the vessel wall by drug-coated hyper-compliant balloon catheters (DCHCB)

Presenter: Maciej Kusmierczuk

September 25, 2018

Presentation TCT Abstracts Posters 2018

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

Presenter: Woo-Young Chung

September 25, 2018

Presentation

Drug transfer to the vessel wall by drug-coated hyper-compliant balloon catheters (DCHCB)

Presenter: Maciej Kusmierczuk

September 25, 2018

Presentation TCT Abstracts Posters 2018

Characterization of Long-Term Mechanical Interaction Between a Bioresorbable Scaffold and Coronary Lesion Throughout Two Years of Scaffold Degradation

Presenter: Tanya Qiu

September 25, 2018

Presentation TCT Abstracts Posters 2018

A Window of External Elastic Membrane Enlargement in Treated Coronary Arteries as a Clinical Target

Presenter: Alexander Kharlamov

September 25, 2018

Presentation TCT Abstracts Posters 2018

Intrapatient randomised study with polymer free DES vs. abluminal biodegradable polymer DES with early OCT follow-up

Presenter: Imanol Otaegui

September 25, 2018

Presentation TCT Abstracts Posters 2018

Comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polimer coated everolimus-eluting Xience stent: 6- and 24-months results of the DESSOLVE III OCT sub-study

Presenter: Krzysztof Milewski

September 25, 2018

Presentation TCT Abstracts Posters 2018

Investigation of Potential Predictors of Irregular Protrusion following Cobalt Chromium Everolimus-Eluting Stent Implantation in Patients with Stable Coronary Artery Disease : Subanalysis of the MECHANISM-Elective study

Presenter: Yuya Taguchi

September 25, 2018

Presentation TCT Abstracts Posters 2018

Increased Risk of Acute Stent Thrombosis Associated with Synergy® Bioabsorbable Polymer-Coated Drug-Eluting Stent after Percutaneous Coronary Intervention for Acute Coronary Syndrome

Presenter: Joel Lardizabal

September 25, 2018

Presentation TCT Abstracts Posters 2018

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

Presenter: Omeed Neghabat

September 25, 2018

Advertisement

Insight from AcoArt I5 Year Follow Up

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

LUTONIX BTK Trial

TOBA II 12-Month Data

1-Year Outcomes for Eluvia in Long Lesions

Show me the Data: Key Clinical Trials of 2018

So Many Choices – How Do I Choose a Stent in 2018?

Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Drug transfer to the vessel wall by drug-coated hyper-compliant balloon catheters (DCHCB)

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

Drug transfer to the vessel wall by drug-coated hyper-compliant balloon catheters (DCHCB)

Characterization of Long-Term Mechanical Interaction Between a Bioresorbable Scaffold and Coronary Lesion Throughout Two Years of Scaffold Degradation

A Window of External Elastic Membrane Enlargement in Treated Coronary Arteries as a Clinical Target

Intrapatient randomised study with polymer free DES vs. abluminal biodegradable polymer DES with early OCT follow-up

Comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polimer coated everolimus-eluting Xience stent: 6- and 24-months results of the DESSOLVE III OCT sub-study

Investigation of Potential Predictors of Irregular Protrusion following Cobalt Chromium Everolimus-Eluting Stent Implantation in Patients with Stable Coronary Artery Disease : Subanalysis of the MECHANISM-Elective study

Increased Risk of Acute Stent Thrombosis Associated with Synergy® Bioabsorbable Polymer-Coated Drug-Eluting Stent after Percutaneous Coronary Intervention for Acute Coronary Syndrome

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content